Table 1. The clinical presentations of EHPVO patients treated by splenectomy for refractory esophagogastric varices.
| Case | Age | Sex | Indication for splenectomy | Prophylactic or bleeding varices | JAK2V617 mutation | MPN |
|---|---|---|---|---|---|---|
| 1 | 44 | M | EGV | Bleeding | - | |
| 2 | 42 | F | EGV | Prophylactic | + | MPN-U |
| 3 | 32 | M | EGV | Bleeding | - | |
| 4 | 47 | F | EGV | Bleeding | + | ET |
| 5 | 27 | F | EGV | Bleeding | - | |
| 6 | 33 | F | GV | Prophylactic | - | |
| 7 | 64 | F | EGV | Bleeding | + | PV |
| 8 | 17 | F | EGV | Bleeding | - |
EGV: esophagogastric varices, ET: essential thrombocythemia, GV: gastric varices, MPN: myeloproliferative neoplasm, MPN-U: myeloproliferative neoplasm, unclassifiable, PV: polycythemia vera.